Research Article
Elevation of Plasma Homocysteine and Minor Hallucinations in Parkinson’s Disease: A Cross-Sectional Study
Table 2
Clinical characteristics of the PD-MH and PD-NH patients.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
aMann-Whitney test. bChi-square test. cThe scores were calculated from the NMS-Quest total score excluding the hallucinations/delusions domain score. dSignificant results are highlighted in bold (). SD: standard deviation; PD: Parkinson’s disease; MH: minor hallucination; NH: no hallucinations; NMS-Quest: Non-Motor Symptoms Questionnaire; PDSS: The PD Sleep Scale; RBDSQ: the REM sleep behavior disorder Sreening Questionnaire; MOCA: Montreal Cognitive Assessment; HAMA: Hamilton Anxiety Rating Scale; HAMD: Hamilton Depression Rating Scale. PDQ39: Parkinson’s Disease Questionnaire-39; Hcy: homocysteine; VB12: vitamin B12. |